EMA/FVE info session for veterinary practitioners: Understanding the first report of sales and use of antimicrobials in animals, Online, European Medicines Agency, Amsterdam, the Netherlands, from 3 June 2025, 15:30 (CEST) to 3 June 2025, 16:30 (CEST)

Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Date of authorisation: 23/10/2012, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR): Busulfan Fresenius Kabi, busulfan, Date of authorisation: 22/09/2014, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Amvuttra, vutrisiran, Date of authorisation: 15/09/2022, Revision: 5, Status: Authorised

Minutes of the COMP meeting 13-15 May 2025

QRD guidance on the use of adopted abbreviations and pictograms on the packaging of veterinary medicinal products authorised via the centralised (CP), mutual recognition (MRP), decentralised (DCP), subsequent recognition (SRP) and national procedures

QRD guidance on the use of adopted abbreviations and pictograms on the packaging of veterinary medicinal products authorised via the centralised (CP), mutual recognition (MRP), decentralised (DCP), subsequent recognition (SRP) and national procedures

Human medicines European public assessment report (EPAR): Constella, linaclotide, Date of authorisation: 26/11/2012, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR): Cimzia, certolizumab pegol, Date of authorisation: 01/10/2009, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR): Livmarli, maralixibat chloride, Date of authorisation: 09/12/2022, Revision: 8, Status: Authorised